Literature DB >> 30922701

Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.

Jerilyn R Izac1, Andrew C Camire1, Christopher G Earnhart1, Monica E Embers1, Rebecca A Funk1, Edward B Breitschwerdt1, Richard T Marconi2.   

Abstract

As Ixodes ticks spread to new regions, the incidence of Lyme disease (LD) in companion animals and humans will increase. Preventive strategies for LD in canines center on vaccination and tick control (acaricides). Both subunit and bacterin based LD veterinary vaccines are available. Outer surface protein C (OspC), a potent immunogen and dominant early antigen, has been demonstrated to elicit protective antibody (Ab) responses. However, a single OspC protein elicits a relatively narrow range of protection. There are conflicting reports as to whether the immunodominant epitopes of OspC reside within variable or conserved domains. A detailed understanding of the antigenic determinants of OspC is essential for understanding immune responses to this essential virulence factor and vaccinogen. Here, we investigate the contribution of the conserved C-terminal C10 motif in OspC triggered Ab responses. Using a panel of diverse recombinant full length OspC proteins and their corresponding C10 deletion variants (OspCΔC10), we demonstrate that the C10 motif does not significantly contribute to immunization or infection induced Ab responses in rabbits, rats, canines, horses and non-human primates. Furthermore, the C10 motif is not required to trigger potent bactericidal Ab responses. This study provides insight into the antigenic structure of OspC. The results enhance our understanding of immune responses that develop during infection or upon vaccination and have implications for interpretation of LD diagnostic assays that employ OspC.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Borrelia; Borreliella; Lyme disease; Lyme disease vaccine; OspC

Year:  2019        PMID: 30922701      PMCID: PMC6453540          DOI: 10.1016/j.vaccine.2019.02.007

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  55 in total

1.  Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi.

Authors:  C Eicken; V Sharma; T Klabunde; R T Owens; D S Pikas; M Höök; J C Sacchettini
Journal:  J Biol Chem       Date:  2001-01-03       Impact factor: 5.157

2.  Geographic uniformity of the Lyme disease spirochete (Borrelia burgdorferi) and its shared history with tick vector (Ixodes scapularis) in the Northeastern United States.

Authors:  Wei-Gang Qiu; Daniel E Dykhuizen; Michael S Acosta; Benjamin J Luft
Journal:  Genetics       Date:  2002-03       Impact factor: 4.562

3.  Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  D Kumaran; S Eswaramoorthy; B J Luft; S Koide; J J Dunn; C L Lawson; S Swaminathan
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

4.  Temporal changes in outer surface proteins A and C of the lyme disease-associated spirochete, Borrelia burgdorferi, during the chain of infection in ticks and mice.

Authors:  T G Schwan; J Piesman
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

5.  Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope.

Authors:  R D Gilmore; M L Mbow
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Crystallization and preliminary X-ray analysis of Borrelia burgdorferi outer surface protein C (OspC).

Authors:  D Kumaran ; S Eswaramoorthy; J J Dunn; S Swaminathan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2001-02

7.  C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.

Authors:  Dean A Jobe; Steven D Lovrich; Ronald F Schell; Steven M Callister
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

Review 8.  Temporal regulation of outer surface proteins of the Lyme-disease spirochaete Borrelia burgdorferi.

Authors:  T G Schwan
Journal:  Biochem Soc Trans       Date:  2003-02       Impact factor: 5.407

9.  OspA immunization decreases transmission of Borrelia burgdorferi spirochetes from infected Peromyscus leucopus mice to larval Ixodes scapularis ticks.

Authors:  J Tsao; A G Barbour; C J Luke; E Fikrig; D Fish
Journal:  Vector Borne Zoonotic Dis       Date:  2001       Impact factor: 2.133

10.  Disease severity in a murine model of lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain.

Authors:  Guiqing Wang; Caroline Ojaimi; Hongyan Wu; Victoria Saksenberg; Radha Iyer; Dionysios Liveris; Steve A McClain; Gary P Wormser; Ira Schwartz
Journal:  J Infect Dis       Date:  2002-08-20       Impact factor: 5.226

View more
  13 in total

1.  Inner Workings: Lyme disease vaccines face familiar challenges, both societal and scientific.

Authors:  Leah Shaffer
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-24       Impact factor: 11.205

2.  FtlA and FtlB Are Candidates for Inclusion in a Next-Generation Multiantigen Subunit Vaccine for Lyme Disease.

Authors:  Andrew C Camire; Nathaniel S O'Bier; Dhara T Patel; Nicholas A Cramer; Reinhard K Straubinger; Edward B Breitschwerdt; Rebecca A Funk; Richard T Marconi
Journal:  Infect Immun       Date:  2022-09-14       Impact factor: 3.609

3.  Antibody profiling of a Borreliella burgdorferi (Lyme disease) C6 antibody positive, symptomatic Rottweiler and her pups.

Authors:  A L Hatke; D R Green; K Stasiak; R T Marconi
Journal:  Vet J       Date:  2020-07-05       Impact factor: 2.688

Review 4.  Laboratory Diagnosis of Lyme Borreliosis.

Authors:  John A Branda; Allen C Steere
Journal:  Clin Microbiol Rev       Date:  2021-01-27       Impact factor: 26.132

5.  Human and Veterinary Vaccines for Lyme Disease.

Authors:  Nathaniel S O'Bier; Amanda L Hatke; Andrew C Camire; Richard T Marconi
Journal:  Curr Issues Mol Biol       Date:  2020-12-08       Impact factor: 2.081

6.  The Leptospiral General Secretory Protein D (GspD), a secretin, elicits complement-independent bactericidal antibody against diverse Leptospira species and serovars.

Authors:  Eja Schuler; R T Marconi
Journal:  Vaccine X       Date:  2021-02-23

7.  The Borrelia burgdorferi Adenylate Cyclase, CyaB, Is Important for Virulence Factor Production and Mammalian Infection.

Authors:  Vanessa M Ante; Lauren C Farris; Elizabeth P Saputra; Allie J Hall; Nathaniel S O'Bier; Adela S Oliva Chávez; Richard T Marconi; Meghan C Lybecker; Jenny A Hyde
Journal:  Front Microbiol       Date:  2021-05-25       Impact factor: 5.640

8.  Comparative analysis of antibody responses to outer surface protein (Osp)A and OspC in dogs vaccinated with Lyme disease vaccines.

Authors:  A C Camire; A L Hatke; V L King; J Millership; D M Ritter; N Sobell; A Weber; R T Marconi
Journal:  Vet J       Date:  2021-04-14       Impact factor: 2.688

9.  Development and optimization of OspC chimeritope vaccinogens for Lyme disease.

Authors:  Jerilyn R Izac; Nathaniel S O'Bier; Lee D Oliver; Andrew C Camire; Christopher G Earnhart; DeLacy V LeBlanc Rhodes; Brandon F Young; Stuart R Parnham; Christopher Davies; Richard T Marconi
Journal:  Vaccine       Date:  2020-01-17       Impact factor: 4.169

10.  Serologic Evidence for the Exposure of Eastern Coyotes (Canis latrans) in Pennsylvania to the Tick-Borne Pathogens Borreliella burgdorferi and Anaplasma phagocytophilum.

Authors:  Jerilyn R Izac; Andrew C Camire; Edward J A Schuler; Amanda L Hatke; Nathaniel S O'Bier; Lee D Oliver; Avery Corondi; Olivia C Plocinski; Russell P Desmond; Waheeda A Naimi; Jason A Carlyon; Kyle R Van Why; Jennifer Shelly; Richard T Marconi
Journal:  mSphere       Date:  2020-08-12       Impact factor: 4.389

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.